Q3 2026 Metropolis Healthcare Ltd Earnings Call Transcript
Key Points
- Metropolis Healthcare Ltd (BOM:542650) reported a strong revenue growth of 26% year-on-year for Q3 FY26, with organic revenue growth at 15%.
- The company launched a Centre of Genomics in Delhi, enhancing its capabilities in advanced molecular testing and precision diagnostics.
- Metropolis Healthcare Ltd (BOM:542650) achieved a significant milestone by receiving its first patent for a system focused on managing TB-related infections.
- The company remains net debt-free with cash reserves of INR127 crore, indicating a strong financial position.
- A bonus issue of shares in the ratio of 3 to 1 was approved, reflecting confidence in long-term growth prospects and rewarding shareholders.
- There was a delay in the launch of the genomics platform due to machine arrival issues, impacting gross margins temporarily.
- The company faced a one-time impact of INR9 crore due to labor code implementation, affecting profitability.
- The diagnostics industry experienced atypical seasonal behavior, with lower-than-expected infection-related diagnostic demand.
- Metropolis Healthcare Ltd (BOM:542650) closed down some labs due to operational realignment, which may indicate challenges in certain areas.
- There is rising competition in the genomics space, with concerns about disruptive pricing from new entrants.
Ladies and gentlemen, good day and welcome to the Q3 FY26 earnings conference call of Metropolis Healthcare Limited, hosted by ICICI Securities.
This conference call may contain forward-looking statements about the company which are based on the beliefs, opinions, and expectations of the company as on the date of this call. These statements do not guarantee the future performance of the company -- (technical difficulty). These statements do not guarantee the future performance of the company, and it may involve risk and uncertainties that are difficult to predict.
As a reminder, all participant lines will be in the listen-only mode, and there will be an opportunity for you to ask questions after the presentation concludes. (Operator Instructions) Please note that this conference is being recorded. I now hand the conference or to Ms. Nisha Shetty from ICICI Securities.
Thank you, and over to you, ma'am.
Thank you, Suam. Good morning. (technical difficulty)
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
